Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Osteoblastoma D018215 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Drowning D004332 2 associated lipids
Jejunal Diseases D007579 3 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Radiculopathy D011843 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
King JN et al. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study. 2010 Res. Vet. Sci. pmid:20004922
Snapper JR et al. Effects of repetitive bolus injections of zymosan-activated plasma on lung mechanics and airway responsiveness in awake sheep. 1991 Am. Rev. Respir. Dis. pmid:2001069
Gibson RL et al. Group B streptococcus induces tumor necrosis factor in neonatal piglets. Effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange. 1991 Am. Rev. Respir. Dis. pmid:2001073
Moore K et al. Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. 1991 Gastroenterology pmid:2001805
Song J and Wander RC Effects of dietary selenium and fish oil (MaxEPA) on arachidonic acid metabolism and hemostatic function in rats. 1991 J. Nutr. pmid:2002400
Zisman E et al. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. 2010 Eur J Anaesthesiol pmid:20035230
Ahmed Y et al. Increased platelet turnover in a patient with previous recurrent pre-eclampsia and failure of aspirin therapy. Case report. 1991 Br J Obstet Gynaecol pmid:2004060
Schnabel FR et al. The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity. 1991 Transplantation pmid:2006526
Muschol W et al. Eicosanoid-mediated increase in glucose and lactate output as well as decrease and redistribution of flow by complement-activated rat serum in perfused rat liver. 1991 Eur. J. Biochem. pmid:2007411
Thomson VS et al. Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events. 2009 Oct-Dec J Postgrad Med pmid:20083870
Santilli F et al. Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. 2010 J. Thromb. Haemost. pmid:20088941
Abraham WM et al. A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep. 1991 Am. Rev. Respir. Dis. pmid:2008991
Petö J et al. Low level of prostacyclin as a risk of ischaemic heart disease. 1991 Int. J. Cardiol. pmid:2010251
Nomura F et al. Enhancement of cardiac prostacyclin release during reperfusion after diltiazem supplemented potassium cardioplegia. 1991 Jan-Feb J Cardiovasc Surg (Torino) pmid:2010447
Srivastava KC and Malhotra N Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets. 1991 Prostaglandins Leukot. Essent. Fatty Acids pmid:2011614
Qureshi AA et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). 1991 Am. J. Clin. Nutr. pmid:2012010
Qureshi AA et al. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. 1991 Am. J. Clin. Nutr. pmid:2012015
Weinblatt M et al. The effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis. 1991 Arthritis Rheum. pmid:2012627
Lin L et al. Role of prostanoids in renin-dependent and renin-independent hypertension. 1991 Hypertension pmid:2013478
Ammoury N et al. Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats. 1991 Pharm. Res. pmid:2014197
Kidson-Gerber G et al. Serum thromboxane B2 compared to five other platelet function tests for the evaluation of aspirin effect in stable cardiovascular disease. 2010 Heart Lung Circ pmid:20144559
Nørregaard R et al. Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissue. 2010 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:20147610
Eldor A et al. In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. 1991 Blood pmid:2015401
Montine TJ et al. Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. 2010 PLoS ONE pmid:20174466
Satoh K et al. Plasma 11-dehydrothromboxane B2: a reliable indicator of platelet hyperfunction in patients with ischemic stroke. 1991 Acta Neurol. Scand. pmid:2017905
Youssef DT et al. New anti-inflammatory sterols from the Red Sea sponges Scalarispongia aqabaensis and Callyspongia siphonella. 2010 Nat Prod Commun pmid:20184014
Kong DL et al. Hemorrhage and intracranial hypertension in combination increase cerebral production of thromboxane A2. 1991 Crit. Care Med. pmid:2019140
Butler BD et al. Circadian study of decompression sickness symptoms and response-associated variables in rats. 2010 Chronobiol. Int. pmid:20205563
Tannirandorn Y et al. Production of urinary 11-keto-thromboxane B2 in normal and hypertensive pregnancies. 1991 Prostaglandins Leukot. Essent. Fatty Acids pmid:2020732
Lordkipanidzé M et al. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease. 2011 Int. J. Cardiol. pmid:20207433
Sinzinger H et al. Enhanced mitotic activity induced by irradiation is abolished by PGI2 pretreatment. 1991 Prostaglandins pmid:2020746
Steib CJ et al. Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis. 2010 Lab. Invest. pmid:20212458
Svensson J and Samuelsson K Inhibition of platelet function by low dose acetylsalicylic acid in patients with cerebrovascular disease. 1983 Thromb. Res. pmid:20218005
Zwergel U et al. Eicosanoid synthesis in the isolated human renal pelvis, ureter and bladder. 1991 Br J Urol pmid:2021808
Wennmalm A et al. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. 1991 Circulation pmid:2022025
Smock KJ and Rodgers GM Laboratory evaluation of aspirin responsiveness. 2010 Am. J. Hematol. pmid:20229592
Warner JH et al. Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers. 2010 BMC Med Res Methodol pmid:20233412
Juvela S et al. Angiographic vasospasm and release of platelet thromboxane after subarachnoid hemorrhage. 1991 Stroke pmid:2024274
Abián J and Gelpí E Characteristic fragmentation of thromboxane B2 in thermospray high-performance liquid chromatography-mass spectrometry. 1991 J. Chromatogr. pmid:2026689
Ishibashi M et al. Novel derivatization and immunoextraction to improve microanalysis of 11-dehydrothromboxane B2 in human urine. 1991 J. Chromatogr. pmid:2026724
Gross PL et al. Platelet function in Watanabe heritable hyperlipidemic rabbits. Decreased sensitivity to thromboxane A2. 1991 May-Jun Arterioscler. Thromb. pmid:2029501
Röth E Effect of Ca-antagonists, beta-blockers and antioxidant during reperfusion period. 1991 Mar-Apr Bratisl Lek Listy pmid:2029661
Watson ED and Sertich PL Concentrations of arachidonate metabolites, steroids and histamine in preovulatory horse follicles after administration of human chorionic gonadotrophin and the effect of intrafollicular injection of indomethacin. 1991 J. Endocrinol. pmid:2030323
Welbourn R et al. Attenuation of IL-2-induced multisystem organ edema by phalloidin and antamanide. 1991 J. Appl. Physiol. pmid:2033005
De La Cruz JP et al. Virgin olive oil administration improves the effect of aspirin on retinal vascular pattern in experimental diabetes mellitus. 2010 Br. J. Nutr. pmid:20350343
Taylor PM et al. Pharmacodynamics and pharmacokinetics of flunixin in the cat: a preliminary study. 1991 Vet. Rec. pmid:2035219
Yao HX et al. [The study of relationship between platelet function and thrombus in patients with essential thrombocythaemia]. 2010 Zhonghua Yi Xue Za Zhi pmid:20356540
Fuchs I et al. Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy. 2010 Crit. Care Med. pmid:20400900
Squadrito F et al. Platelet activating factor involvement in splanchnic artery occlusion shock in rats. 1991 Eur. J. Pharmacol. pmid:2040364
Vannier E et al. Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs. 1991 J. Clin. Invest. pmid:2040687
Ideguchi M Experimental studies on the effect of total thoracic esophagectomy on cardiorespiratory functions and the plasma concentration of chemical mediators. 1991 Jpn J Surg pmid:2041245
Sato R et al. Inhibition of secretory phospholipase A2 activity attenuates lipopolysaccharide-induced acute lung injury in a mouse model. 2010 Exp. Lung Res. pmid:20426527
Oldenhof J et al. Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2. 2010 Curr Med Res Opin pmid:20429831
Oviedo PJ et al. Progestogens reduce thromboxane production by cultured human endothelial cells. 2011 Climacteric pmid:20443717
Qu C et al. Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2. 2010 J. Pharmacol. Exp. Ther. pmid:20444882
Panchenko VM et al. [Characteristics of disorders of thrombocytic hemostasis in patients with recurrent myocardial infarction]. 1991 Kardiologiia pmid:2046245
Foo LC et al. Platelets of habitual smokers have reduced susceptibility to aggregating agent. 1991 Thromb. Haemost. pmid:2048056
Alusik S et al. The inhibitory effect of statins on urinary 11-dehydrothromboxane levels. 2010 Int Angiol pmid:20502413
Mangalpally KK et al. Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. 2010 J. Thromb. Thrombolysis pmid:20502945
Véricel E et al. Chick nutritional encephalomalacia and prostanoid formation. 1991 J. Nutr. pmid:2051239
Schwarcz TH et al. Prostacyclin production in the area of arterial endothelial denudation. 1991 J. Surg. Res. pmid:2051776
Kawaguchi T et al. The human megakaryocytic cell line UT-7/TPO expresses functional platelet agonist signals mediated through GPVI and thromboxane receptor. 2010 Cell Biol. Int. pmid:20522022
Lagarde M et al. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. 1978 Br. J. Haematol. pmid:205238
Boizel R et al. Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes. 2010 Diabetologia pmid:20535444
Ferrante E et al. Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 2010 Free Radic. Biol. Med. pmid:20541603
Liang XC and Guo SS [Effect of jiang-zhi zhong-yao-pian on total cholesterol, triglyceride, TXB2, 6-keto-PGF1 alpha in hyperlipemic patients]. 1991 Zhong Xi Yi Jie He Za Zhi pmid:2054886
Horgan MJ et al. Mechanism of endothelin-1-induced pulmonary vasoconstriction. 1991 Circ. Res. pmid:2054931
Nagase T et al. Intravenous bolus of prednisolone decreases 15-hydroxyeicosatetraenoic acid formation in the rat model of acid aspiration. 1991 Crit. Care Med. pmid:2055084
Cholette JM et al. Aspirin resistance following pediatric cardiac surgery. 2010 Thromb. Res. pmid:20550971
Masumura H et al. A thromboxane A2 synthase inhibitor, DP-1904, prevents rat renal injury. 1991 Eur. J. Pharmacol. pmid:2055246
Gordge MP et al. Haemostatic activation and proteinuria as factors in the progression of chronic renal failure. 1991 Nephrol. Dial. Transplant. pmid:2057112
Fukushima H et al. Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin. 2010 Am. J. Med. Genet. A pmid:20583254
Cheng Y and Li ZK [Changes of neurotransmitter endothelin, thromboxance B2 and 6-keto-prostaglandin F1 alpha in patients with chronic pulmonary heart disease]. 2010 Nan Fang Yi Ke Da Xue Xue Bao pmid:20584647
Mucha I et al. Factors affecting the reliability of direct radioimmunoassay for urinary 11-dehydrothromboxane B2 with 125I-labelled ligand: albumin and heterogeneous immunoreactivity. 1991 Eicosanoids pmid:2059455
Moore JN et al. Effects of a linseed oil enriched diet on endotoxin-induced sequelae: differential in vitro and in vivo effects. 1991 Eicosanoids pmid:2059458
Tosaki A et al. Effect of cicletanine on reperfusion-induced arrhythmias and its relation to 6-keto-PGF1 alpha and thromboxane B2 release. 1991 Can. J. Physiol. Pharmacol. pmid:2059911
Derhaschnig U et al. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia. 2010 Platelets pmid:20608787
Kawabata K et al. Inhibition of secretory phospholipase A2 activity attenuates acute cardiogenic pulmonary edema induced by isoproterenol infusion in mice after myocardial infarction. 2010 J. Cardiovasc. Pharmacol. pmid:20625313
Viganò G et al. Recombinant human erythropoietin to correct uremic bleeding. 1991 Am. J. Kidney Dis. pmid:2063854
Boutaud O and Oates JA Study of inhibitors of the PGH synthases for which potency is regulated by the redox state of the enzymes. 2010 Methods Mol. Biol. pmid:20645166
Saihkay HN et al. Validating 123I-metaiodobenzylguanidine as a platelet marker for non-invasive imaging in rabbits. 2011 Jan-Feb J Pharmacol Toxicol Methods pmid:20646985
Gambini G et al. Absence of effects of ketanserin on renal prostacyclin and thromboxane A2 in essential hypertension. 1991 Eur. Heart J. pmid:2065689
Huang HC et al. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats. 2010 J. Gastroenterol. Hepatol. pmid:20659230
Basselin M et al. Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats. 2011 J. Cereb. Blood Flow Metab. pmid:20664612
pmid:20667508
Dharmasaroja PA and Sae-Lim S Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. 2010 Blood Coagul. Fibrinolysis pmid:20689403
Milara J et al. Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences. 2010 Br. J. Pharmacol. pmid:20698855
Gerrard JM et al. The structured interview elicits a differential prostacyclin response in A and B behaviour types. 1991 Can J Cardiol pmid:2070285
Bollinger JG et al. Improved sensitivity mass spectrometric detection of eicosanoids by charge reversal derivatization. 2010 Anal. Chem. pmid:20704368
Yassine HN et al. Clinical determinants of aspirin resistance in diabetes. 2010 Diabetes Res. Clin. Pract. pmid:20719400
Würtz M et al. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets. 2010 JACC Cardiovasc Interv pmid:20723855
Genda T [Effects of prostaglandins on pulmonary circulation]. 1991 Masui pmid:2072519
Hampton KK et al. Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo. 1990 Thromb. Haemost. pmid:2073296
Facino RM et al. Phytochemical characterization and radical scavenger activity of flavonoids from Helichrysum italicum G. Don (Compositae). 1990 Nov-Dec Pharmacol. Res. pmid:2075159
Nagy S et al. A canine model of hyperdynamic sepsis induced by intestinal ischemia. 1990 Acta Physiol Hung pmid:2075825
Hora K et al. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy. 1990 Nephron pmid:2077412
Parmar JH et al. Significant prostacyclin/thromboxane level imbalance after lower limb arterial angioplasty: a possible platelet function alteration. 2010 J Vasc Interv Radiol pmid:20800778
Ito T et al. Role of activated platelets in endotoxin-induced DIC in rats. 1990 Thromb. Res. pmid:2080492
Anauate MC et al. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay. 2010 Phytother Res pmid:20812280
Greer IA Effects of ketorolac tromethamine on hemostasis. 1990 Pharmacotherapy pmid:2082316